Acute Myeloid Leukemia (AML) Market Size, Trends, and Growth Analysis 2026-2033 The Acute Myeloid Leukemia (AML) market presents robust growth potential, driven by rising prevalence and advancements in targeted therapies. This complex oncology segment displays dynamic market trends, fueled by innovative treatments and strategic market players pushing boundaries in research and development. The AML market size and revenue trajectory indicates a strong upward progression during the forecast period, highlighting significant business growth opportunities. Market Size and Overview The Acute Myeloid Leukemia (AML) market is estimated to be valued at USD 1.74 billion in 2025 and is expected to reach USD 2.92 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032. https://www.coherentmi.com/industry-reports/acute-myeloid-leukemia-aml-market